While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

这项被称为人体研究#3或GLP-1-H24-3的研究旨在确定是否能通过Lexaria专利DehydraTECH技术，以口服胶囊形式有效地将Zepbound®的活性成分替雷肽输送到人体血液中。研究结果显示，口服胶囊在研究结束时达到了与注射药物大致相当的血药浓度水平。根据InvestingPro分析，尽管公司在过去12个月收入增长达77.6%，但仍在持续投入大量研发资金，分析师预计今年尚无法实现盈利。

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...

Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...